NCT00034151View on ClinicalTrials.gov

Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Ovarian Cancer
Interventions
DRUG

S-8184 Paclitaxel Injectable Emulsion

Sponsors
All Listed Sponsors
lead

Achieve Life Sciences

INDUSTRY